PIRAMAL PHARMA: CO HAS RECEIVED SBTI APPROVAL FOR ITS COMMITMENT TO REDUCE SCOPE 1 AND 2 GHG EMISSIONS BY 42% AND SCOPE 3 BY 25% BY FY 2030 PIRAMAL PHARMA: CO HAS RECEIVED SBTI APPROVAL FOR ITS COMMITMENT TO REDUCE SCOPE 1 AND 2 GHG EMISSIONS BY 42% AND SCOPE 3 BY 25% BY FY 2030

Posted on by Raj Gaurav Rai

PIRAMAL PHARMA: CO HAS RECEIVED SBTI APPROVAL FOR ITS COMMITMENT TO REDUCE SCOPE 1 AND 2 GHG EMISSIONS BY 42% AND SCOPE 3 BY 25% BY FY 2030 PIRAMAL PHARMA: CO HAS RECEIVED SBTI APPROVAL FOR ITS COMMITMENT TO REDUCE SCOPE 1 AND 2 GHG EMISSIONS BY 42% AND SCOPE 3 BY 25% BY FY 2030

Please follow and like us:
fb-share-icon
Tweet
Pin Share

Related Posts

NTPC Q1 ResultNET PROFIT 45.10B RUPEES VS 40.7B (YOY)REVENUE 444.19B RUPEES VS 391.22B (YOY)EBITDA 124.46B RUPEES VS 113.69B (YOY)EBITDA MARGIN 28.02% VS 29.06% (YOY) #StockMarket #FinancialNews #Trading https://earnfree.in/ NTPC Q1 ResultNET PROFIT 45.10B RUPEES VS 40.7B (YOY)REVENUE 444.19B RUPEES VS 391.22B (YOY)EBITDA 124.46B RUPEES VS 113.69B (YOY)EBITDA MARGIN 28.02% VS 29.06% (YOY) #StockMarket #FinancialNews #Trading https://earnfree.in/

NTPC Q1 Result NET PROFIT 45.10B RUPEES VS 40.7B (YOY) REVENUE 444.19B RUPEES VS 391.22B (YOY) EBITDA 124.46B RUPEES VS 113.69B (YOY) EBITDA MARGIN 28.02% […]